
Join to View Full Profile
3410 Worth StDept of Gynecologic OncologyDallas, TX 75246
Phone+1 214-370-1301
Fax+1 214-370-1318
Are you Dr. Oh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Oh, MD is an obstetrician/gynecologist in Dallas, Texas. He is currently licensed to practice medicine in Texas.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2001 - 2004
- University of Texas Southwestern Medical CenterResidency, Obstetrics and Gynecology, 1997 - 2001
- University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
- TX State Medical License 1998 - 2026
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 3 citationsCorrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol....Jonathan Oh, Minal A. Barve, Neil Senzer, Phylicia Aaron, Luisa Manning
Gynecologic Oncology Reports. 2021-03-01 - 76 citationsGemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.Rodney P. Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. Chan, Minal A. Barve
The Lancet. Oncology. 2020-12-01 - 20 citationsLong-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance.Johnathan Oh, Minal A. Barve, Neil Senzer, Phylicia Aaron, Luisa Manning
Gynecologic Oncology Reports. 2020-09-17